K. A. Rye, C. A. Bursill, G. Lambert, F. Tabet, and P. J. Barter, The metabolism and anti-atherogenic properties of HDL, The Journal of Lipid Research, vol.50, issue.Supplement, pp.195-200, 2009.
DOI : 10.1194/jlr.R800034-JLR200

A. Kontush and M. J. Chapman, Functionally Defective High-Density Lipoprotein: A New Therapeutic Target at the Crossroads of Dyslipidemia, Inflammation, and Atherosclerosis, Pharmacological Reviews, vol.58, issue.3, pp.342-374, 2006.
DOI : 10.1124/pr.58.3.1

L. Thomson, P. L. Fox, H. Ischiropoulos, J. D. Smith, M. Kinter et al., Apolipoprotein, 2004.

D. L. Macdonald, T. L. Terry, L. B. Agellon, P. N. Nation, F. et al., Administration of Tyrosyl Radical-Oxidized HDL Inhibits the Development of Atherosclerosis in Apolipoprotein E-Deficient Mice, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.23, issue.9, 2003.
DOI : 10.1161/01.ATV.0000085840.67498.00

G. Davi and C. Patrono, Platelet Activation and Atherothrombosis, New England Journal of Medicine, vol.357, issue.24, pp.2482-2494, 2007.
DOI : 10.1056/NEJMra071014

T. Nakano and A. Nagata, Immunochemical detection of circulating oxidized high-density lipoprotein with antioxidized apolipoprotein A-I monoclonal antibody, Journal of Laboratory and Clinical Medicine, vol.141, issue.6, pp.378-384, 2003.
DOI : 10.1016/S0022-2143(03)00026-X

J. R. Nofer, M. F. Brodde, and B. E. Kehrel, High-density lipoproteins, platelets and the pathogenesis of atherosclerosis, Clinical and Experimental Pharmacology and Physiology, vol.89, issue.7, pp.726-735, 2010.
DOI : 10.1111/j.1440-1681.2010.05377.x

C. C. Shoulders, D. J. Brett, J. D. Bayliss, T. M. Narcisi, A. Jarmuz et al., Abetalipoproteinemia is caused by defects of the gene encoding the 97 kDa subunit of a microsomal triglyceride transfer protein, Human Molecular Genetics, vol.2, issue.12, pp.2109-2116, 1993.
DOI : 10.1093/hmg/2.12.2109

M. F. Linton, R. V. Farese, Y. , and S. G. , ) Familial hypobetalipoproteinemia, J. Lipid Res, vol.34, pp.521-541, 1993.

P. Tarugi, Variable phenotypic expression of homozygous familial hypobetalipoproteinaemia due to novel APOB gene mutations, Clin. Genet, vol.74, pp.267-273, 2008.

I. I. Surya, M. Mommersteeg, G. Gorter, D. W. Erkelens, and J. W. And-akkerman, Abnormal platelet functions in a patient with abetalipoproteinemia, Thromb. Haemost, vol.65, pp.306-311, 1991.

M. Aviram, R. J. Deckelbaum, and J. G. Brook, Platelet function in a case with abetalipoproteinemia, Atherosclerosis, vol.57, issue.2-3, pp.313-323, 1985.
DOI : 10.1016/0021-9150(85)90043-7

K. M. Shastri, A. C. Carvalho, and R. S. Lees, Platelet function and platelet lipid composition in the dyslipoproteinemias, J. Lipid Res, vol.21, pp.467-472, 1980.

R. J. Havel, H. A. Eder, and J. H. And-bragdon, THE DISTRIBUTION AND CHEMICAL COMPOSITION OF ULTRACENTRIFUGALLY SEPARATED LIPOPROTEINS IN HUMAN SERUM, Journal of Clinical Investigation, vol.34, issue.9, pp.1345-1353, 1955.
DOI : 10.1172/JCI103182

M. Lagarde, P. A. Bryon, M. Guichardant, and M. Dechavanne, A simple and efficient method for platelet isolation from their plasma, Thrombosis Research, vol.17, issue.3-4, pp.581-588, 1980.
DOI : 10.1016/0049-3848(80)90098-5

D. E. Bowyer, W. M. Leat, A. N. Howard, and G. A. Gresham, The determination of the fatty acid composition of serum lipids separated by thin-layer chromatography; and a comparison with column chromatography, Biochimica et Biophysica Acta, vol.70, pp.423-431, 1963.
DOI : 10.1016/0006-3002(63)90772-8

G. V. Born, Aggregation of Blood Platelets by Adenosine Diphosphate and its Reversal, Nature, vol.14, issue.4832, pp.927-929, 1962.
DOI : 10.1016/0006-3002(61)90250-5

D. Boukhchache and M. Lagarde, Interactions between prostaglandin precursors during their oxygenation by human platelets, Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, vol.713, issue.2, pp.386-392, 1982.
DOI : 10.1016/0005-2760(82)90257-0

C. Calzada, L. Coulon, D. Halimi, L. Coquil, E. Pruneta-deloche et al., Glycoxidized Low-Density Lipoproteins and Low-Density Lipoproteins Isolated from Type 2 Diabetic Patients Activate Platelets via p38 Mitogen-Activated Protein Kinase, The Journal of Clinical Endocrinology & Metabolism, vol.92, issue.5, pp.1961-1964, 2007.
DOI : 10.1210/jc.2006-2045

URL : https://hal.archives-ouvertes.fr/inserm-00267256

R. Colas, A. Sassolas, M. Guichardant, C. Cugnet-anceau, M. Moret et al., LDL from obese patients with the metabolic syndrome show increased lipid peroxidation and activate platelets, Diabetologia, vol.29, issue.11, pp.2931-2940, 2011.
DOI : 10.1007/s00125-011-2272-8

URL : https://hal.archives-ouvertes.fr/inserm-00616814

H. Imachi, K. Murao, W. Cao, S. Tada, T. Taminato et al., Expression of Human Scavenger Receptor B1 on and in Human Platelets, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.23, issue.5, pp.898-904, 2003.
DOI : 10.1161/01.ATV.0000067429.46333.7B

C. Patrono, F. , and G. A. , Isoprostanes: Potential Markers of Oxidant Stress in Atherothrombotic Disease, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.17, issue.11, pp.2309-2315, 1997.
DOI : 10.1161/01.ATV.17.11.2309

E. Granot and R. Kohen, Oxidative stress in abetalipoproteinemia patients receiving long-term vitamin E and vitamin A supplementation, Am. J. Clin. Nutr, vol.79, pp.226-230, 2004.

J. R. Nofer and M. Van-eck, HDL scavenger receptor class B type I and platelet function, Current Opinion in Lipidology, vol.22, issue.4, 2011.
DOI : 10.1097/MOL.0b013e32834701de

M. Valiyaveettil, N. Kar, M. Z. Ashraf, T. V. Byzova, M. Febbraio et al., Oxidized high-density lipoprotein inhibits platelet activation and aggregation via scavenger receptor BI, Blood, vol.111, issue.4, pp.1962-1971, 2008.
DOI : 10.1182/blood-2007-08-107813

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2234045

D. Gao, M. Z. Ashraf, N. S. Kar, D. Lin, L. M. Sayre et al., Structural Basis for the Recognition of Oxidized Phospholipids in Oxidized Low Density Lipoproteins by Class B Scavenger Receptors CD36 and SR-BI, Journal of Biological Chemistry, vol.285, issue.7, pp.4447-4454, 2010.
DOI : 10.1074/jbc.M109.082800

A. Assinger, W. Schmid, S. Eder, D. Schmid, E. Koller et al., Oxidation by hypochlorite converts protective HDL into a potent platelet agonist, FEBS Letters, vol.10, issue.5, pp.778-784, 2008.
DOI : 10.1016/j.febslet.2008.02.001

N. G. Ardlie, M. L. Selley, and L. A. Simons, Platelet activation by oxidatively modified low density lipoproteins, Atherosclerosis, vol.76, issue.2-3, pp.117-124, 1989.
DOI : 10.1016/0021-9150(89)90094-4

Y. Takahashi, H. Chiba, K. Matsuno, H. Akita, S. P. Hui et al., Native Lipoproteins Inhibit Platelet Activation Induced by Oxidized Lipoproteins, Biochemical and Biophysical Research Communications, vol.222, issue.2, pp.453-459, 1996.
DOI : 10.1006/bbrc.1996.0765

M. E. Kingwell, B. A. , and J. S. , Reconstituted high-density lipoprotein attenuates platelet function in individuals with type 2 diabetes mellitus by promoting cholesterol efflux, Circulation, vol.120, pp.2095-2104, 2009.

M. F. Brodde, S. J. Korporaal, G. Herminghaus, M. Fobker, T. J. Van-berkel et al., Native high-density lipoproteins inhibit platelet activation via scavenger receptor BI, Atherosclerosis, vol.215, issue.2, pp.374-382, 2011.
DOI : 10.1016/j.atherosclerosis.2010.12.026